Chimerix, Inc is a biotechnology business based in the US. Chimerix shares (CMRX) are listed on the NASDAQ and all prices are listed in US Dollars. Chimerix employs 54 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Chimerix
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CMRX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Chimerix stock price (NASDAQ: CMRX)Use our graph to track the performance of CMRX stocks over time.
Chimerix shares at a glance
|Latest market close||$7.82|
|52-week range||$2.22 - $11.57|
|50-day moving average||$7.79|
|200-day moving average||$8.69|
|Wall St. target price||$17.83|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.32|
Buy Chimerix shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Chimerix stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Chimerix price performance over time
|1 week (2021-07-24)||N/A|
|1 month (2021-07-02)||-6.12%|
|3 months (2021-05-04)||-9.07%|
|6 months (2021-01-31)||N/A|
|1 year (2020-07-31)||N/A|
|2 years (2019-07-31)||N/A|
|3 years (2018-07-31)||N/A|
|5 years (2016-07-31)||N/A|
|Revenue TTM||$5.6 million|
|Gross profit TTM||$-30,860,000|
|Return on assets TTM||-22.6%|
|Return on equity TTM||-111.23%|
|Market capitalisation||$598.3 million|
TTM: trailing 12 months
Shorting Chimerix shares
There are currently 3.2 million Chimerix shares held short by investors – that's known as Chimerix's "short interest". This figure is 5.9% down from 3.4 million last month.
There are a few different ways that this level of interest in shorting Chimerix shares can be evaluated.
Chimerix's "short interest ratio" (SIR)
Chimerix's "short interest ratio" (SIR) is the quantity of Chimerix shares currently shorted divided by the average quantity of Chimerix shares traded daily (recently around 719325.95936795). Chimerix's SIR currently stands at 4.43. In other words for every 100,000 Chimerix shares traded daily on the market, roughly 4430 shares are currently held short.
However Chimerix's short interest can also be evaluated against the total number of Chimerix shares, or, against the total number of tradable Chimerix shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Chimerix's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Chimerix shares in existence, roughly 40 shares are currently held short) or 0.0479% of the tradable shares (for every 100,000 tradable Chimerix shares, roughly 48 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Chimerix.
Find out more about how you can short Chimerix stock.
Chimerix share dividends
We're not expecting Chimerix to pay a dividend over the next 12 months.
Chimerix share price volatility
Over the last 12 months, Chimerix's shares have ranged in value from as little as $2.22 up to $11.5696. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Chimerix's is 1.5696. This would suggest that Chimerix's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Chimerix, Inc. , a development-stage biopharmaceutical company, focuses on accelerating the advancement of various medicines that impact in the lives of patients living with cancer and other serious diseases. Its clinical stage development programs include brincidofovir (BCV), an antiviral drug candidate in development as a medical countermeasure for smallpox; dociparstat sodium (DSTAT), which inhibits the activities of key proteins implicated in the resistance of acute myeloid leukemia blasts and leukemic stem cells to chemotherapy; and ONC201 a program for potentially treating tumors which harbor the H3 K27M mutation in recurrent diffuse midline glioma patients. The company has license agreements with Biomedical Advanced Research and Development Authority for the development of brincidofovir for use in the treatment of smallpox; Cantex Pharmaceuticals, Inc. to develop and commercialize a glycosaminoglycan compound; and SymBio Pharmaceuticals to develop, manufacture, and commercialize BCV for various human indications. Chimerix, Inc. was incorporated in 2000 and is headquartered in Durham, North Carolina.
Stocks similar to Chimerix
Chimerix in the news
Chimerix to Present at 2021 Wedbush PacGrow Healthcare Conference
Chimerix to Present at 2021 Wedbush PacGrow Healthcare Conference
Chimerix to Report Second Quarter 2021 Financial Results and Provide an Operational Update on August 5, 2021
Frequently asked questionsWhat percentage of Chimerix is owned by insiders or institutions?
Currently 12.37% of Chimerix shares are held by insiders and 60.6% by institutions. How many people work for Chimerix?
Latest data suggests 54 work at Chimerix. When does the fiscal year end for Chimerix?
Chimerix's fiscal year ends in December. Where is Chimerix based?
Chimerix's address is: 2505 Meridian Parkway, Durham, NC, United States, 27713 What is Chimerix's ISIN number?
Chimerix's international securities identification number is: US16934W1062 What is Chimerix's CUSIP number?
Chimerix's Committee on Uniform Securities Identification Procedures number is: 16934W106
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert